Oxford Biomedica plc (LON:OXB)
London · Delayed Price · Currency is GBP · Price in GBX 853.00
-22.00 (-2.51%)
Jan 22, 2026, 4:35 PM GMT
Oxford Biomedica Market Cap
Oxford Biomedica has a market cap or net worth of 1.06 billion as of January 22, 2026. Its market cap has increased by 142.08% in one year.
Market Cap
1.06B
Enterprise Value
1.11B
Revenue
151.21M
Ranking
n/a
PE Ratio
n/a
Stock Price
853.00
Market Cap Chart
Since September 22, 1997, Oxford Biomedica's market cap has increased from 17.39M to 1.06B, an increase of 5,974.54%. That is a compound annual growth rate of 15.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 1.06B | 42.07% |
| Dec 31, 2025 | 743.72M | 67.15% |
| Dec 31, 2024 | 444.94M | 108.92% |
| Dec 29, 2023 | 212.97M | -50.00% |
| Dec 30, 2022 | 425.96M | -59.79% |
| Dec 31, 2021 | 1.06B | 24.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genus | 1.85B |
| Oxford Nanopore Technologies | 1.45B |
| PureTech Health | 314.67M |
| Avacta Group | 229.72M |
| Faron Pharmaceuticals Oy | 198.16M |
| Scancell Holdings | 134.91M |
| Bioventix | 94.05M |
| 4basebio | 91.32M |